What drugs are in the pancrelipase class?
Pancrelipase is a digestive enzyme replacement therapy. Drugs in this class contain pancreatic enzymes—typically lipase, amylase, and protease—used to help people break down fats, starches, and proteins when the pancreas does not make enough digestive enzymes.
Common product names in this drug class include:
- Creon (pancrelipase)
- Zenpep (pancrelipase)
- Pancreaze (pancrelipase)
What conditions is pancrelipase used for?
Pancrelipase products are used when pancreatic enzyme production is low. The main condition associated with this therapy is pancreatic insufficiency, most often due to cystic fibrosis and other causes of exocrine pancreatic insufficiency.
How do pancrelipase products differ if they are the same class?
Even when products are all “pancrelipase,” they can differ in:
- Strength/formulation (how much enzyme activity is provided)
- Dosage forms and timing (for example, capsule vs. delayed-release formulations)
- How enzymes are released in the gut (which can affect how patients take them with meals)
Are there patent or brand-exclusivity issues with pancrelipase products?
Brand-name pancrelipase products have had separate patent and exclusivity timelines depending on the specific formulation and manufacturer. DrugPatentWatch.com tracks this kind of information by product, including patent status and filings. You can check a specific brand (for example, Creon, Zenpep, or Pancreaze) for up-to-date patent details on DrugPatentWatch.com: https://www.drugpatentwatch.com/